Literature DB >> 12240797

Drug safety without borders: concerns about bupropion.

Barbara Mintzes, Ken Bassett, James M Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240797      PMCID: PMC121939     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Postmarketing drug surveillance: what it would take to make it work.

Authors: 
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

2.  Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-01-08       Impact factor: 8.262

Review 3.  Prescription-event monitoring--recent progress and future horizons.

Authors:  R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

4.  Drugs and adverse drug reactions: how worried should we be?

Authors:  D W Bates
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

5.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

6.  Under-reporting of adverse drug reactions in general practice.

Authors:  Y Moride; F Haramburu; A A Requejo; B Bégaud
Journal:  Br J Clin Pharmacol       Date:  1997-02       Impact factor: 4.335

  6 in total
  2 in total

1.  Adverse events with Zyban (buproprion).

Authors:  Michael Kolber; G Richard Spooner; Olga Szafran
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

2.  Bupropion-Induced Delayed-Onset Anaphylaxis.

Authors:  Cameron J Risma; Matthew J Pazderka; Yon J Chong; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.